跳至主要内容
临床试验/NCT05077605
NCT05077605
已完成
不适用

Electrical Impedance Tomography: Effect of Extubation on Functional Residual Capacity

Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer1 个研究点 分布在 1 个国家目标入组 34 人2021年11月5日

概览

阶段
不适用
干预措施
Functional residual capacity measure by electrical impedance tomography
疾病 / 适应症
Functional Residual Capacity
发起方
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
入组人数
34
试验地点
1
主要终点
End Expiratory Lung Impedance (EELI)
状态
已完成
最后更新
19天前

概览

简要总结

The extubation phase is a risky period of anesthesia management. During this step, serious complications can arise: hypoxemia, laryngospasm, pharyngeal obstruction, pneumonia… In spite of these complications, extubation and its impact on respiratory function, particularly on the Functional Residual Capacity (FRC), remains poorly studied because of the difficulty to make bedside measurements.

The PulmoVista 500 is a clinical routine which provide effective non-invasive bedside measurements. It would be interesting to evaluate the impact of extubation on respiratory function, and more specifically FRC changes during and after extubation.

This study will allow a better physiopathological knowledge and a quality improvement patient extubation management.

详细描述

The aim of this study is to evaluate the variation of functional residual capacity and its distribution before and after extubation. Patients with scheduled surgery and receiving general anesthesia with orotracheal intubation are included and the measurements will be performed in the post-interventional monitoring room (PICU). EELI data will be collected before extubation and then at T0, then T5, T10, T15 and T20 minutes. No subsequent follow-up is required.

注册库
clinicaltrials.gov
开始日期
2021年11月5日
结束日期
2022年6月30日
最后更新
19天前
研究类型
Interventional
研究设计
Single Group
性别
All

研究者

发起方
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
责任方
Sponsor

入排标准

入选标准

  • Patient over 18 years
  • Patient in operating room for scheduled surgery
  • Patient receiving general anaesthesia with orotracheal intubation
  • Patient given written consent after information
  • Patient covered by social security or equivalent regimen

排除标准

  • Patient undergoing thoracic and spinal surgery, due to the presence of dressings that interfere with measurements,
  • Patient who has undergone intracerebral surgery because of possible communication difficulties upon awakening,
  • Patients with a body mass index (BMI) \> 50 (measurements not possible)
  • Pregnant or breastfeeding patient,
  • Patient contraindicated to the use of a thoracic electroimpedancemetry technique: dressings, wounds, presence of a pacemaker, defibrillator or any other active implant.
  • Patient deprived of liberty by a judicial or administrative decision or patient subject to a legal protection measure (guardianship, curatorship...)
  • Patient in a period of exclusion from another research protocol
  • Any other reason that, in the opinion of the investigator, could interfere with the evaluation of study objectives

研究组 & 干预措施

Functional residual capacity

Functional residual capacity measure during and after extubation

干预措施: Functional residual capacity measure by electrical impedance tomography

结局指标

主要结局

End Expiratory Lung Impedance (EELI)

时间窗: Between 2 and 3 hours

EELI variation before and at different timepoints after extubation: T0, T5, T10, T15 and T20 (min).

次要结局

  • Tidal volume distribution depending on patient position(Between 2 and 3 hours)
  • Tidal volume distribution(Between 2 and 3 hours)
  • Tidal volume distribution depending on surgery type and duration(Between 2 and 3 hours)
  • Tidal volume distribution depending on ventilatory mode(Between 2 and 3 hours)

研究点 (1)

Loading locations...

相似试验